Maria Dan

402 total citations
22 papers, 319 citations indexed

About

Maria Dan is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Maria Dan has authored 22 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Maria Dan's work include Hematopoietic Stem Cell Transplantation (4 papers), Antifungal resistance and susceptibility (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Maria Dan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Antifungal resistance and susceptibility (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Maria Dan collaborates with scholars based in United States, Romania and United Kingdom. Maria Dan's co-authors include Ayad Al‐Katib, Ramzi M. Mohammad, Mary Varterasian, Lyle L. Sensenbrenner, Muhammad Shurafa, Ayad Al-Katib, Joseph P. Uberti, Anthony J. Murgo, Nathan R. Wall and Thomas H. Corbett and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Molecules.

In The Last Decade

Maria Dan

20 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Dan United States 10 121 94 62 61 50 22 319
Aisha Masood United States 12 205 1.7× 232 2.5× 67 1.1× 76 1.2× 66 1.3× 35 465
Y Elisseyeff United States 9 205 1.7× 133 1.4× 34 0.5× 17 0.3× 185 3.7× 10 556
PJ Burke United States 6 221 1.8× 106 1.1× 19 0.3× 53 0.9× 191 3.8× 9 489
John Michael Kilpatrick United States 10 183 1.5× 47 0.5× 34 0.5× 92 1.5× 44 0.9× 11 427
Metello Iacobini Italy 10 121 1.0× 56 0.6× 17 0.3× 110 1.8× 39 0.8× 26 281
Elke Malenke Germany 9 126 1.0× 82 0.9× 20 0.3× 92 1.5× 30 0.6× 13 303
Kwang-Sung Ahn South Korea 11 195 1.6× 76 0.8× 24 0.4× 29 0.5× 100 2.0× 18 317
Andrew Hertler United States 11 120 1.0× 76 0.8× 31 0.5× 287 4.7× 43 0.9× 18 428
Chengcheng Meng United States 11 162 1.3× 59 0.6× 14 0.2× 61 1.0× 74 1.5× 16 336
N Tsuruoka Japan 11 133 1.1× 63 0.7× 38 0.6× 131 2.1× 35 0.7× 30 350

Countries citing papers authored by Maria Dan

Since Specialization
Citations

This map shows the geographic impact of Maria Dan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Dan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Dan more than expected).

Fields of papers citing papers by Maria Dan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Dan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Dan. The network helps show where Maria Dan may publish in the future.

Co-authorship network of co-authors of Maria Dan

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Dan. A scholar is included among the top collaborators of Maria Dan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Dan. Maria Dan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Dan, Maria, et al.. (2012). [Etiology of ventilator-associated pneumonia at the Cardiovascular Surgery Clinic of Iaşi].. PubMed. 116(1). 15–21.
4.
Dan, Maria, et al.. (2011). [Fungi as emergent etiologic agents in ventilator-associated pneumonia after cardiac surgery].. PubMed. 114(4). 1077–82. 3 indexed citations
5.
Dan, Maria, et al.. (2006). [Disseminated infections due to Scedosporium apiospermum in a patient with anaplastic large cell lymphoma. A case study].. PubMed. 109(3). 638–41. 1 indexed citations
6.
Dan, Maria & Charles A. Schiffer. (2003). Strategies for managing refractoriness to platelet transfusions.. PubMed. 2(2). 158–64. 8 indexed citations
7.
Vaishampayan, Ulka N. & Maria Dan. (2002). Unusual Hematologic Malignancies. Journal of Clinical Oncology. 20(17). 3739–3742. 4 indexed citations
8.
Mohammad, Ramzi M., Yousif Abubakr, Maria Dan, et al.. (2002). Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.. PubMed. 8(4). 1277–83. 15 indexed citations
9.
Varterasian, Mary, Ramzi M. Mohammad, Muhammad Shurafa, et al.. (2000). Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.. PubMed. 6(3). 825–8. 78 indexed citations
10.
Zheng, Guoguang, et al.. (1999). Expression of Membrane-Associated Macrophage Colony-Stimulating Factor (M-CSF) in Hodgkin's Disease and Other Hematologic Malignancies. Leukemia & lymphoma. 32(3-4). 339–344. 15 indexed citations
11.
Aref, Amr, Samuel Tekyi‐Mensah, Mary Varterasian, et al.. (1999). Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma. Radiation Oncology Investigations. 7(3). 186–191. 21 indexed citations
12.
Dan, Maria, et al.. (1998). Answer to Photo Quiz I. Clinical Infectious Diseases. 26(6). 1439–1439. 2 indexed citations
13.
Mohamed, Anwar N., et al.. (1996). Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 86(2). 143–146. 18 indexed citations
14.
LoRusso, Patricia, Lisa Demchik, Maria Dan, et al.. (1995). Comparative efficacy of DMP 840 against mouse and human solid tumor models. Investigational New Drugs. 13(3). 195–203. 5 indexed citations
15.
Redman, Bruce G., Ta‐Hsu Chou, Mark M. Zalupski, et al.. (1995). Phase I Trial of Sequential Cyclophosphamide, Cyclosporin A, and Interferon-α in Patients with Cancer. Journal of Immunotherapy. 18(2). 115–118. 1 indexed citations
16.
LeVeque, Francis G., et al.. (1994). Oral cytomegalovirus infection in an unrelated bone marrow transplantation with possible mediation by graft-versus-host disease and the use of cyclosporin-A. Oral Surgery Oral Medicine Oral Pathology. 77(3). 248–253. 9 indexed citations
17.
Ratanatharathorn, Voravit, Joseph P. Uberti, Chatchada Karanes, et al.. (1994). Phase I study of alpha-interferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantation.. PubMed. 13(5). 625–30. 23 indexed citations
18.
Al-Katib, Ayad, Ramzi M. Mohammad, Khalid M. Khan, et al.. (1993). Bryostatin 1-Induced Modulation of the Acute Lymphoblastic Leukemia Cell Line Reh. Journal of Immunotherapy. 14(1). 33–42. 22 indexed citations
19.
Ueda, Mikio, Indira Joshi, Maria Dan, et al.. (1993). Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.. PubMed. 56(2). 351–6. 26 indexed citations
20.
Verani, Regina & Maria Dan. (1982). Membranous Glomerulonephritis in Renal Transplant. American Journal of Nephrology. 2(6). 316–320. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026